SNDX Stock Analysis: Buy, Sell, or Hold?
SNDX - Syndax Pharmaceuticals, Inc.
$23.88
0.52 (2.23%)
▲
5d:
-1.32%
30d:
+11.59%
90d:
+15.14%
BUY
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 04, 2026
Smart Money Accumulation
SNDX is down 3.1% this week, but smart money is accumulating calls. Top strike: $26 2026-05-15 with 110 OI. Call ratio: 100% View Scanner →
Strength: 6.5/10
Get Alerted When SNDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SNDX shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: SNDX shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SNDX is currently trading at $23.88, which is considered slightly high relative to its 30-day fair value range of $21.55 to $24.32. From a valuation perspective, the stock is trading at a discount (Forward PE: -40.0) compared to its historical average (126.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SNDX is in a strong uptrend. Immediate support is located at $22.40, while resistance sits at $25.59.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $38.45 (+61.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNDX is in a strong uptrend. Immediate support is located at $22.40, while resistance sits at $25.59.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $38.45 (+61.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$21.55 -
$24.32
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 61.0% below Wall St target ($38.45)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Fair Price Analysis
30-Day Fair Range
$21.55 -
$24.32
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$22.40
Resistance Level
$25.59
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-39.98
Wall Street Target
$38.45
(+61.0%)
Revenue Growth (YoY)
794.9%
Profit Margin
-165.6%
PE vs Historical
-40.0 vs 126.3
CHEAP
Share & Embed Analysis
Last updated: April 02, 2026 4:32 AM ET
Data refreshes hourly during market hours. Next update: 5:32 AM
Data refreshes hourly during market hours. Next update: 5:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Keith A Goldan
SELL
3410 shares
2026-02-09
Michael A Metzger
SELL
17159 shares
2026-02-09
Keith A Goldan
SELL
2082 shares
2026-02-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 52 HOLD |
Advanced SNDX Option Strategies
Professional options setups generated by AI based on today's SNDX price and gamma walls.
